LAMA (long-acting muscarinic antagonist) treatments may be more beneficial to people with stable chronic obstructive pulmonary disease (COPD) than those with LABA…
Articles by Joana Fernandes, PhD
The National Heart, Lung and Blood Institute (NHLBI)Â of the National Institutes of Health has granted $10 million to the…
Treatment with a triple combo therapy in a single inhaler decreased exacerbation rates in COPD patients compared with tiotropium treatment,…
Metered-dose inhalers are a common device among patients with lung diseases, including chronic obstructive pulmonary disease (COPD), but users may…
The Aerobika device, which Monaghan Medical Corporation (MMC) developed to ease symptoms of chronic obstructive pulmonary disease (COPD), may also…
A sugar molecule called keratan sulfate could play a protective role against inflammation and emphysema associated with chronic obstructive pulmonary…
A protein called Wnt5a seems to be involved in the development of chronic obstructive pulmonary disease (COPD), according to a…